Moreover, SERPINE2 contributes to enhanced invasion, metastasis, and stemness of cancer cells by remodeling the tumor matrix, and has been identified as a poor biomarker for endometrial cancer (43). This evidence concerns the gene SERPINE2 and neoplasm.